Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 3/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.58 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | POLB | P06746 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | ALPL | P05186 | 1/20 | 0.57 |
| ▸ | ALPI | P09923 | 1/20 | 0.57 |
| ▸ | ALPG | P10696 | 1/20 | 0.57 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | PLEC | Q15149 | 1/20 | 0.55 |
| ▸ | CA9 | Q16790 | 11/20 | 0.51 |
| ▸ | CA1 | P00915 | 9/20 | 0.51 |
| ▸ | CA2 | P00918 | 9/20 | 0.51 |
| ▸ | CA12 | O43570 | 4/20 | 0.51 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.51 |
| ▸ | CA7 | P43166 | 3/20 | 0.49 |
| ▸ | ESR1 | P03372 | 1/20 | 0.49 |
| ▸ | ALB | P02768 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20056705 | 0.93 | USP2 (0.69) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL22107769 | 0.92 | USP2 (0.64) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL24594128 | 0.90 | USP2 (0.64) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL20256560 | 0.89 | USP2 (0.59) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL23762550 | 0.88 | USP2 (0.57) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL22650188 | 0.87 | USP2 (0.64) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL18211419 | 0.87 | USP2 (0.61) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL23158776 | 0.87 | USP2 (0.56) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL12061907 | 0.85 | USP2 (0.66) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL12045940 | 0.84 | USP2 (0.68) | USP2L3MBTL1DNASE1L3PRMT1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3455299-B1 | COMPOSITIONS COMPRISING A POLYMERIC DYE AND A CYCLODEXTRIN AND USES THEREOF | SONY GROUP CORP (JP) | 2024-01-17 | — | — | EP | disclosed |
| US-20220220373-A1 | FLUORESCENT PROBES FOR MONOACYLGLYCEROL LIPASE (MAGL) | HOFFMANN-LA ROCHE INC. (US) | 2022-07-14 | — | — | US | disclosed |
| WO-2021062176-A2 | POLYMERIC TANDEM DYES WITH LINKER GROUPS | SONY CORPORATION (JP) | 2021-04-01 | — | — | WO | disclosed |
| WO-2020210692-A1 | PROGRAMMABLE POLYMERIC DRUGS | SONY CORPORATION (JP) | 2020-10-15 | — | — | WO | disclosed |
| WO-2020210694-A1 | PROGRAMMABLE POLYMERIC DRUGS | SONY CORPORATION (JP) | 2020-10-15 | — | — | WO | disclosed |
| WO-2019182765-A1 | USE OF DIVALENT METALS FOR ENHANCEMENT OF FLUORESCENT SIGNALS | SONY CORPORATION (JP) | 2019-09-26 | — | — | WO | disclosed |
| WO-2019182766-A1 | POLYMERIC TANDEM DYES WITH LINKER GROUPS | SONY CORPORATION (JP) | 2019-09-26 | — | — | WO | disclosed |
| WO-2019118714-A1 | IONIC POLYMERS COMPRISING BIOLOGICALLY ACTIVE COMPOUNDS | SONY CORPORATION (JP) | 2019-06-20 | — | — | WO | disclosed |
| WO-2019071208-A1 | PROGRAMMABLE POLYMERIC DRUGS | SONY CORPORATION (JP) | 2019-04-11 | — | — | WO | disclosed |
| WO-2017214165-A1 | IONIC POLYMERS COMPRISING FLUORESCENT OR COLORED REPORTER GROUPS | SONY CORPORATION (JP) | 2017-12-14 | — | — | WO | disclosed |
| WO-2017177065-A2 | ULTRA BRIGHT DIMERIC OR POLYMERIC DYES WITH SPACING LINKER GROUPS | SONY CORPORATION (JP) | 2017-10-12 | — | — | WO | disclosed |
| EP-2534170-B1 | IAP BIR DOMAIN BINDING COMPOUNDS | PHARMASCIENCE INC (CA) | 2017-04-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220220373-A1 | FLUORESCENT PROBES FOR MONOACYLGLYCEROL LIPASE (MAGL) | MGLL, LPL, LIPA | USP2 1191/4885L3MBTL1 154/4885DNASE1L3 410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.